Biobot Analytics measures pathogens and chemical biomarkers in municipal wastewater and applies proprietary analytics and machine-learning models to turn those measurements into predictive, community-level public-health intelligence. Its monitoring panels track more than 50 human-health trends, including respiratory viruses, gastrointestinal and arboviral pathogens, opioids, stimulants, and treatment medications, with forecasts designed to surface disease and substance-use activity ahead of clinical and official reporting.
The company sells wastewater intelligence to pharmaceutical and life-science companies, healthcare systems, federal agencies, state and local governments, and wastewater treatment plants. Its work supports nationwide monitoring programs contracted with the U.S. Department of Health and Human Services and the White House Office of National Drug Control Policy, and it holds NIH Small Business Innovation Research awards across Phase I, II, and III.
